By Dennis Thompson HealthDay ReporterWEDNESDAY, April 29, 2026 (HealthDay News) — A new way of using umbilical cord blood — ...
A new way of using umbilical cord blood for treating blood diseases could make the treatment more accessible to patients who ...
NYBCe and CZ Biohub will derive iPSC lines from cord blood's immune cells, creating shared, broadly compatible resources for cell therapy, disease modelling, and AI-driven drug development.
The BLA approval is supported by data from the COBLT study, FDA dockets and public information, and from a RegeneCyte observational database. The Food and Drug Administration (FDA) has approved the ...
Umbilical cord blood is used as a source of hematopoietic stem cells for patients with blood cancers and other life-threatening disorders when matched donors are unavailable. Umbilical cord blood ...
NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- New York Blood Center Enterprises (NYBCe) and Human Life CORD Japan Inc. (Human Life CORD) have signed a Letter of Intent to expand their manufacturing ...
A treatment to move blood from the umbilical cord into an infant's body may provide a safe option for preterm infants born after 28 weeks who need rapid support, suggests a new study. The procedure, ...
Giving birth to a child who is unresponsive or struggling to breathe is a harrowing experience. The medical team must quickly cut the umbilical cord and then rush the baby to aid. But taking a few ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results